XML 38 R24.htm IDEA: XBRL DOCUMENT
v3.24.1.u1

Business Segments and Geographic Information | 6 Months Ended
--- | ---
Mar. 30, 2024
Segment Reporting [Abstract] |
Business Segments and Geographic Information | Business Segments and Geographic Information The Company has four reportable segments: Diagnostics, Breast Health, GYN Surgical and Skeletal Health. The Company measures and evaluates its reportable segments based on segment revenues and operating income adjusted to exclude the effect of non-cash charges (such as intangible asset amortization expense, and goodwill and intangible asset impairment charges), transaction and integration expenses for acquisitions, restructuring, consolidation and divestiture charges, litigation charges, and other one-time or unusual items. Identifiable assets for the reportable segments consist of inventories, intangible assets, goodwill, and property, plant and equipment. The Company fully allocates depreciation expense to its reportable segments. The Company has presented all other identifiable assets as corporate assets. There were no inter-segment revenues during the three and six months ended March 30, 2024 and April 1, 2023. Segment information is as follows:
| Three Months Ended |  | Six Months Ended
| March 30, 2024 |  | April 1, 2023 |  | March 30, 2024 |  | April 1, 2023
Total revenues: |  |  |  |  |  |  |
Diagnostics | $ | 450.1 |  |  | $ | 464.7 |  |  | $ | 897.9 |  |  | $ | 1,024.0 |
Breast Health | 384.6 |  |  | 385.4 |  |  | 762.3 |  |  | 719.5 |
GYN Surgical | 156.0 |  |  | 144.8 |  |  | 318.2 |  |  | 298.9 |
Skeletal Health | 27.1 |  |  | 31.6 |  |  | 52.5 |  |  | 58.3 |
| $ | 1,017.8 |  |  | $ | 1,026.5 |  |  | $ | 2,030.9 |  |  | $ | 2,100.7 |
Income from operations: |  |  |  |  |  |  |
Diagnostics | $ | 71.1 |  |  | $ | 105.3 |  |  | $ | 120.5 |  |  | $ | 256.4 |
Breast Health | 91.7 |  |  | 109.9 |  |  | 193.8 |  |  | 170.4 |
GYN Surgical | 44.3 |  |  | 52.3 |  |  | 87.6 |  |  | 101.0 |
Skeletal Health | 3.3 |  |  | 4.6 |  |  | 6.7 |  |  | 6.7 |
| $ | 210.4 |  |  | $ | 272.1 |  |  | $ | 408.6 |  |  | $ | 534.5 |
Depreciation and amortization: |  |  |  |  |  |  |
Diagnostics | $ | 51.5 |  |  | $ | 56.1 |  |  | $ | 117.4 |  |  | $ | 116.0 |
Breast Health | 10.0 |  |  | 12.9 |  |  | 20.3 |  |  | 26.5 |
GYN Surgical | 12.1 |  |  | 11.6 |  |  | 24.1 |  |  | 23.9 |
Skeletal Health | 0.1 |  |  | 0.2 |  |  | 0.3 |  |  | 0.3 |
| $ | 73.7 |  |  | $ | 80.8 |  |  | $ | 162.1 |  |  | $ | 166.7 |
Capital expenditures: |  |  |  |  |  |  |
Diagnostics | $ | 19.8 |  |  | $ | 20.2 |  |  | $ | 44.0 |  |  | $ | 36.1 |
Breast Health | 5.4 |  |  | 6.9 |  |  | 14.7 |  |  | 14.1 |
GYN Surgical | 2.5 |  |  | 2.8 |  |  | 6.7 |  |  | 6.7 |
Skeletal Health | 0.3 |  |  | 0.1 |  |  | 0.4 |  |  | 0.2 |
Corporate | — |  |  | 2.1 |  |  | 0.2 |  |  | 4.1 |
| $ | 28.0 |  |  | $ | 32.1 |  |  | $ | 66.0 |  |  | $ | 61.2 |
| March 30, 2024 |  | September 30, 2023
Identifiable assets: |  |  |
Diagnostics | $ | 2,520.1 |  |  | $ | 2,596.4 |
Breast Health | 1,212.9 |  |  | 1,170.1 |
GYN Surgical | 1,440.2 |  |  | 1,455.4 |
Skeletal Health | 30.8 |  |  | 33.7 |
Corporate | 3,510.4 |  |  | 3,883.7 |
| $ | 8,714.4 |  |  | $ | 9,139.3 |
The Company had no customers that represented greater than 10% of consolidated revenues during the three and six months ended March 30, 2024 and April 1, 2023. The Company operates in the following major geographic areas noted in the below chart. Revenue data is based upon customer location. Other than the United States, no single country accounted for more than 10% of consolidated revenues. The Company’s sales in Europe are predominantly derived from the United Kingdom, Germany, France, Spain, Italy and the Netherlands. The Company’s sales in Asia-Pacific are predominantly derived from China, Australia and Japan. The “Rest of World” designation includes Canada, Latin America and the Middle East. Revenues by geography as a percentage of total revenues were as follows:
| Three Months Ended |  | Six Months Ended
| March 30, 2024 |  | April 1, 2023 |  | March 30, 2024 |  | April 1, 2023
United States | 74.6 | % |  | 74.9 | % |  | 74.5 | % |  | 75.8 | %
Europe | 13.5 | % |  | 14.8 | % |  | 13.8 | % |  | 14.2 | %
Asia-Pacific | 6.3 | % |  | 6.4 | % |  | 6.3 | % |  | 6.1 | %
Rest of World | 5.6 | % |  | 3.9 | % |  | 5.4 | % |  | 3.9 | %
| 100.0 | % |  | 100.0 | % |  | 100.0 | % |  | 100.0 | %

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 22 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 15 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-15 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 31 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 42 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 40 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org//280/tableOfContent Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 26 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-26 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 34 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-34 Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 41 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41 Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 21 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-21 Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 21 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-21 Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (e) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32 + Details
Name: | us-gaap_SegmentReportingDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration